The 20 Best Pseudomyxoma Peritonei Doctors Near Me in Berkeley, CA

Joel Baumgartner is a General Surgeon practicing medicine in La Jolla, California. Dr. Baumgartner is rated as an Elite provider by MediFind in the treatment of Pseudomyxoma Peritonei. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Pseudomyxoma Peritonei, Melanoma, Colorectal Cancer, Gastrostomy, and Tissue Biopsy.

As a gynecologic oncologist I strive to put the patient at the center of her multidisciplinary care and provide the most caring, leading-edge cancer treatments. Dr. Karam is rated as a Distinguished provider by MediFind in the treatment of Pseudomyxoma Peritonei. He is also highly rated in 48 other conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Vulvar Cancer, Oophorectomy, and Hysterectomy. Dr. Karam is board certified in OB & Gyn (Sub: Gynecologic Oncology), OB & Gyn (Sub: Hospice And Palliative Medicine), and Obstetrics & Gynecology. Dr. Karam is currently accepting new patients.

Andrew Lowy is a General Surgeon practicing medicine in La Jolla, California. Dr. Lowy is rated as a Distinguished provider by MediFind in the treatment of Pseudomyxoma Peritonei. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pseudomyxoma Peritonei, Familial Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection.

Dr. Mihaela C. Cristea is a UCI Health hematologist oncologist who specializes in the treatment of gynecologic cancers.She earned her medical degree from the University of Medicine and Pharmacy of Iasi, Romania. She completed a residency in internal medicine at Monmouth Medical Center in Long Branch, N.J. She then completed a fellowship in medical oncology at the University of Florida - Health Science Center, Jacksonville.Her research focuses on evaluating novel therapies to improve patient outcomes in gynecologic malignancies. She has contributed to over 50 peer-reviewed publications in prominent medical journals.Cristea, who also speaks Romanian, brings extensive experience to UCI Health Chao Family Comprehensive Cancer Center. Dr. Cristea is rated as a Distinguished provider by MediFind in the treatment of Pseudomyxoma Peritonei. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Lung Cancer, Ovarian Carcinosarcoma, and Endoscopy.

Dr. Maheswari Senthil is a board-certified UCI health surgical oncologist who specializes in the management of gastric cancer, peritoneal malignancies and advanced abdominal cancers and retroperitoneal sarcomas.An internationally recognized surgical leader in the management of peritoneal carcinomatosis, she offers leading-edge clinical trials that span the breadth of intraperitoneal chemotherapy, novel diagnostic approaches and cytoreduction surgery with heated intraperitoneal chemotherapy. She is the principal investigator of EA 2234 STOPGAP II trial, a national randomized controlled trial for patients with gastric carcinomatosis, investigating the survival benefits of normothermic intraperitoneal paclitaxel combined with systemic therapy.Senthil earned her medical degree at Madurai Medical college in Tamilnadu, India, graduating in the top one percent of her class. She completed a residency in general surgery at Rutger's University in New Jersey and a fellowship in surgical oncology at City of Hope in Duarte, Calif. She is the Chief of the Division of Surgical Oncology and the Director of the Peritoneal Malignancy Program at UC Irvine School of Medicine.Her research interests include design of treatment and diagnostic clinical trials to test treatment approaches for managing advanced cancers. She also is studying a novel-exosome-based liquid biopsy for detection of peritoneal carcinomatosis and a peritoneal carcinomatosis tumor model to design new treatment approaches. She is the medical director of the Institute of Clinical and Translational Science and supports investigators as they develop new biomarkers for early cancer detection.Through bedside to bench to bedside translational research and technical excellence, Senthil seeks to improve diagnosis and treatment of patients with advanced cancers. Her focus is on healing the body as well as the mind and spirit.Nickname: Magi. Dr. Senthil is rated as a Distinguished provider by MediFind in the treatment of Pseudomyxoma Peritonei. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Colorectal Cancer, Pseudomyxoma Peritonei, Breast Cancer, Pancreaticoduodenectomy, and Gastrostomy. Dr. Senthil is board certified in American Board Of Surgery - Surgery (General Surgery).

Dr. Jason A. Zell is a board-certified UCI Health hematology-oncology specialist who focuses on the prevention and treatment of colon and other gastrointestinal cancers.He received his medical degree from Nova Southeastern University, Fort Lauderdale, Fla. He completed his internal medicine residency training and hematology-oncology fellowship at the UCI School of Medicine, via the American Board of Internal Medicine Research Pathway.Zell has received extramural research funding from the National Institutes of Health (NIH) to perform genetic epidemiology-based colorectal cancer research, and is principle investigator or co-investigator for several NIH-funded Phase 2 clinical trials involving patients with gastrointestinal malignancies.Within SWOG, a clinical trials organization of the National Clinical Trials Network, he is the cancer control and prevention liaison to the gastrointestinal committee. Additionally, he is national principal investigator for S0820, a large multicenter, randomized Phase 3 trial involving risk reduction among resected colon cancer patients, which is supported by the NIH National Cancer Institute Division of Cancer Prevention, and conducted by SWOG. He has published more than 70 manuscripts and two book chapters. Dr. Zell is rated as a Distinguished provider by MediFind in the treatment of Pseudomyxoma Peritonei. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Colorectal Cancer, Lynch Syndrome, Colonoscopy, and Endoscopy. Dr. Zell is board certified in American Board Of Internal Medicine - Medical Oncology.

"Dr. Oliver S. Eng is a board-certified UCI Health surgical oncologist who specializes in the treatment of advanced gastrointestinal cancers, including peritoneal and metastatic malignancies, sarcomas and neuroendocrine tumors.He is an expert in treating abdominal cancers, particularly those that have spread to the peritoneum, the membrane lining the abdominal cavity. He also specializes in complex cytoreductive surgery with heated intraperitoneal chemotherapy (HIPEC). This type of high-dose chemotherapy, which is effective for many different types of cancer, is performed in the operating room after surgical removal of all visible signs of disease.Eng earned his medical degree at Rutgers Robert Wood Johnson Medical School in New Brunswick. N.J., where he also completed a residency in general surgery. He also completed a fellowship in complex general surgical oncology at City of Hope in Duarte, Calif. He came to UCI Health and the UCI School of Medicine from the University of Chicago Medical Center, where he helped oversee one of the nation's leading peritoneal surface malignancy programs.His research focus is on the molecular and immunologic characteristics of peritoneal tumors in order to develop innovative therapies for metastatic disease as well as to improve care and optimize outcomes for patients. He is co-author of numerous peer-reviewed manuscripts in such leading journals asCancer Discovery,Cancer, theBritish Journal of CancerandJAMA Surgery. He also has presented his work at national and international conferences and has served as a principal investigator or co-investigator on numerous clinical trials.In 2021, he was named one of the ""40 under 40"" rising stars in cancer by The Lynx Group, a medical communications company specializing in oncology and complex drugs. He also sits on the editorial boards of scientific journals and national committees in his field.". Dr. Eng is rated as a Distinguished provider by MediFind in the treatment of Pseudomyxoma Peritonei. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Pseudomyxoma Peritonei, Stomach Cancer, Colorectal Cancer, Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery. Dr. Eng is board certified in American Board Of Surgery - Complex General Surgical Oncology and American Board Of Surgery - Surgery (General Surgery).

Dr. Ravi Patel is a board certified Medical Oncologist who has been practicing for more than 30 years. He completed his residency at the University of Illinois after obtaining a medical degree from Gujarat University Medical College in India. He went on to complete a fellowship in Hematology/ Oncology from Loyola University Stritch School of Medicine.From the early stages of his career, Dr. Patel was exposed to and focused on bone marrow transplantation along with a wide variety of oncology and hematology training.Dr. Patel founded Comprehensive Blood & Cancer Center in 1984, growing it from a 1,200 square foot office with one employee into the comprehensive, community focused, diagnostic, treatment, educational and research-based cancer center it is today with over 250 employees and a 120,000 square foot campus.While serving as managing director of the center, Dr. Patel continues to actively care for his patients and serve as principal investigator on the center's many clinical research studies. Dr. Patel is actively involved with the leading pharmaceutical manufacturers and academic research programs to assure that cancer patients in Kern County have access to the most cutting-edge medicines and treatments available anywhere in the world.Through choosing to work with the UCLA Jonsson Comprehensive Cancer Center TRIO-US Network, UCLA employees manage clinical trials alongside CBCC's own research staff. Several of the treatments tested at CBCC have proven to be highly successful and have gone on to receive approval from the Federal Government's Food and Drug Administration (FDA). These breakthrough treatments have changed the way many forms of cancer are now being managed around the world.As a result of his clinical research experience, Dr. Patel has authored several scientific papers in such respected journals as the Journal of Clinical Oncology and Clinical Lymphoma. He is sought after as a lecturer and consultant on clinical oncology issues and patient care. He serves as an Associate Clinical Professor of Medicine at UCLA and is actively involved with the Residency Program in Internal Medicine at the Kern County Medical Center. Dr. Patel is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. He is also highly rated in 55 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Ampullary Cancer, Paget Disease of the Breast, and Large-Cell Immunoblastic Lymphoma. Dr. Patel is board certified in Internal Medicine and Internal Medicine (Sub: Medical Oncology). Dr. Patel is currently accepting new patients.

Since childhood, I dreamt of providing care to the needy. My experience with cancer in my family propelled me to seek a medical career and contribute to the advancement of this field. I chose to become a cancer surgeon to fulfill this dream. Lately, I've been focused on understanding and improving the concept of a healthy body and mind. I like to read, and build things with my kids.I personally like the thought process behind Humankindness, it's my philosophy of care too. Give to the world the best you have, and the best will come back to you. Dr. Singla is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Colorectal Cancer, Colorectal Cancer, Splenectomy, and Hernia Surgery. Dr. Singla is board certified in Surgery (Sub: Complex General Surgical Oncology) and Surgery General Surgery. Dr. Singla is currently accepting new patients.

Dr. Michael Yen, MD PhD completed his oncology training at Stanford University in 2008. He has both MD and PhD degrees from the Medical Scientist Training Program at UC San Diego, where he studied the immune system, completing his doctoral thesis in 2000. Dr. Yen went to the Internal Medicine residency program at Parkland Memorial Hospital in Dallas, TX, and finished in 2003. He returned to Stanford University to complete his fellowship in Medical Oncology and Postdoctoral Fellowship in Developmental Biology by 2007. Dr. Yen is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Chronic Lymphocytic Leukemia (CLL), Paget Disease of the Breast, and Colorectal Cancer. Dr. Yen is currently accepting new patients.

Jasdeepa Nagi is a Hematologist practicing medicine in Sacramento, California. Dr. Nagi is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Ovarian Carcinosarcoma, Sertoli-Leydig Cell Tumor, Familial Pancreatic Cancer, and Familial Colorectal Cancer. Dr. Nagi is board certified in Hematology Medical Oncology. Dr. Nagi is currently accepting new patients.

Wei-chien Lin is an Oncologist practicing medicine in Santa Clarita, California. Dr. Lin is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Malignant Mixed Mullerian Tumor, Neuroendocrine Carcinoma of the Cervix, Oophorectomy, and Salpingo-Oophorectomy. Dr. Lin is currently accepting new patients.

Dr. Amy McMullen, MD is board-certified in both Hematology and Medical Oncology from Stanford University. She also did her undergraduate work at Stanford University, where she majored in both Music and Biology. Dr. McMullen then attended Washington University School of Medicine, and she completed her Internal Medicine residency at Harvard Medical School's program at Beth Israel Deaconess Medical Center. Dr. McMullen is devoted to providing personalized compassionate care to all her patients. She and her husband have two children and enjoy being part of the Santa Cruz community. Dr. Mcmullen is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. She is also highly rated in 25 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Virilizing Ovarian Tumor, and Ovarian Carcinosarcoma. Dr. Mcmullen is board certified in Internal Medicine (Sub: Hematology) and Internal Medicine (Sub: Medical Oncology). Dr. Mcmullen is currently accepting new patients.

Gregory Graves is a General Surgeon practicing medicine in Sacramento, California. Dr. Graves is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Undifferentiated Pleomorphic Sarcoma, Familial Colorectal Cancer, Colostomy, and Hernia Surgery. Dr. Graves is board certified in Surgery. Dr. Graves is currently accepting new patients.

Vijay Trisal is a Surgical Oncologist and a General Surgeon practicing medicine in Duarte, California. Dr. Trisal is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Rhabdomyosarcoma Embryonal, Undifferentiated Pleomorphic Sarcoma, Adult Soft Tissue Sarcoma, Rhabdomyosarcoma, and Gastrectomy.

Byrne Lee is a Surgical Oncologist practicing medicine in Palo Alto, California. Dr. Lee is rated as a Distinguished provider by MediFind in the treatment of Pseudomyxoma Peritonei. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Pseudomyxoma Peritonei, Colorectal Cancer, Adult Soft Tissue Sarcoma, Ileostomy, and Pancreatectomy.

Jula Veerapong is a General Surgeon practicing medicine in La Jolla, California. Dr. Veerapong is rated as a Distinguished provider by MediFind in the treatment of Pseudomyxoma Peritonei. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Pseudomyxoma Peritonei, Colorectal Cancer, Gastrointestinal Fistula, Appendectomy, and Hernia Surgery.

Mustafa Raoof is a Surgical Oncologist practicing medicine in Duarte, California. Dr. Raoof is rated as a Distinguished provider by MediFind in the treatment of Pseudomyxoma Peritonei. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Pseudomyxoma Peritonei, Familial Colorectal Cancer, Hepatectomy, and Pancreatectomy.

Marilyn Norton is an Oncologist practicing medicine in Chula Vista, California. Dr. Norton is rated as a Distinguished provider by MediFind in the treatment of Pseudomyxoma Peritonei. She is also highly rated in 78 other conditions, according to our data. Her clinical expertise encompasses Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, Paget Disease of the Breast, Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration.

Isaac Paz is a Surgical Oncologist practicing medicine in South Pasadena, California. Dr. Paz is rated as a Distinguished provider by MediFind in the treatment of Pseudomyxoma Peritonei. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Stomach Cancer, Breast Cancer, Familial Colorectal Cancer, Small Bowel Resection, and Gastrectomy.